ArticlePediatric research2026
Causal relationship between gut microbiota and blood metabolites with childhood Obesity: a Mendelian randomization study.
Article in Pediatric research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThis study aims to explore the causal relationship between gut microbiota and childhood obesity and to assess the potential mediating role of blood metabolites in this relationship.
methodsThis study covering 473 gut microbiota and 1400 metabolites. The bidirectional two-sample Mendelian Randomization method is employed, with Inverse Variance Weighted as the main statistical approach, to assess the causal relationships between gut microbiota, metabolites and Childhood Obesity.
resultsThe study found significant causal associations between 12 types of gut microbiota and childhood obesity, with 7 microbiota showing a negative correlation and 5 acting as risk factors for obesity. Bacillaceae A showed the strongest association with childhood obesity (OR = 0.0481, P = 0.0126), while Eubacterium Q was identified as a major risk bacterium for obesity (OR = 5.4330, P = 0.0452). Additionally, 18 metabolites were found to be associated with childhood obesity, with 6-bromotryptophan being the strongest negatively correlated metabolite (OR = 0.5680, P = 0.00023) and methylsuccinate being the strongest positively correlated risk metabolite (OR = 1.6987, P = 0.0383). Mediation analysis identified 10 significant pathways, highlighting Adrenate (22:4n6) as a mediator for the gut microbiota UBA2922 sp900313925 in promoting childhood obesity (mediation effect: 0.106, mediation proportion: 10.94%), and X-12830 as a mediator for K10 sp001941205 in inhibiting childhood obesity (mediation effect: -0.0772, mediation proportion: 13.68%).
conclusionThis study provides novel evidence of the causal roles of gut microbiota and blood metabolites in childhood obesity. The identification of key metabolites mediating the effects of gut microbiota on obesity risk offers potential targets for future interventions and therapeutic strategies. IMPACT: Analysis revealed 12 gut microbiota causally related to childhood obesity, with seven negatively correlated and five identified as risk factors. Bacillaceae A (protective) and Eubacterium Q (risk) were notably associated. Among 1400 metabolites studied, 18 showed causal relationships with obesity, notably 6-bromotryptophan (protective) and methylsuccinate (risk factor). Mediation analysis identified 10 significant causal pairings between gut microbiota and blood metabolites, with Adrenate (22:4n6) mediating the promotion of childhood obesity by UBA2922 sp900313925, and X-12830 mediating the inhibition of childhood obesity by K10 sp001941205.
Indexed as
Identifiers
40998999What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.